Previous 10 | Next 10 |
2023-04-29 04:20:36 ET Summary Demographic trends are powerful and experience little impact from economic cycles. As the Millennial generation enters middle age and surpasses the number of Baby Boomers, the demand for medical screening and testing will increase. Exact Sciences...
2023-04-21 13:09:23 ET Legend Biotech ( NASDAQ: LEGN ) is up ~10% in Friday afternoon trading after releasing abstracts, the results of which were leaked on Tuesday, on its CAR-T therapy Carvykti (ciltacabtagene autoleucel). The results were accidentally released ...
2023-04-19 14:00:09 ET Geron Corporation ( NASDAQ: GERN ) and CTI BioPharma ( NASDAQ: CTIC ) were among notable gainers in the blood cancer space after an accidental data release from a Phase 3 trial for multiple myeloma therapy Carvykti developed by Legend Biotech ( LEG...
2023-04-19 12:49:23 ET Gainers: SAI.TECH Global Corporation ( SAI ) +48% . Bed Bath & Beyond ( BBBY ) +40% . VYNE Therapeutics ( VYNE ) +34% . Boqii Holding Limited ( BQ ) +30% . CXApp ( CXAI ) +19% . Western Alliance Ban...
2023-04-19 12:40:19 ET Shares of Legend Biotech (NASDAQ: LEGN) surged by more than 20% on Wednesday morning after a data leak regarding one of its clinical trials. The abstract, obtained by drug industry trade publication Fierce Pharma, came from a new phase 3 CARTITUDE-4 trial. It ...
2023-04-19 11:46:07 ET Summary Shares of Legend Biotech rose after a leaked EHA abstract showed a robust treatment effect of Carvykti in the CARTITUDE-4. The hazard ratio of 0.26 was much better than my expectations of a ratio of at least below 0.50 and possibly/likely below 0.40....
Legend Biotech Corporation (NASDAQ: LEGN) is one of today's top gainers. The company's shares are currently up 15.03% on the day to $60.09. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell t...
2023-04-19 10:32:27 ET Legend Biotech ( NASDAQ: LEGN ) extended pre-market gains in regulator trading on Wednesday after announcing a private placement with an institutional investor to sell as many as ~7.7M company shares. The transaction is part of a subscription agreement t...
2023-04-19 10:05:08 ET Gainers: Vyne Therapeutics ( VYNE ) +32% . Ensysce Biosciences ( ENSC ) +23% . Legend Biotech ( LEGN ) +20% . Tempest Therapeutics ( TPST ) +16% . Evoke Pharma ( EVOK ) +14% . Losers: Allarity T...
Legend Biotech Corporation (“Legend Biotech” or the “Company”) (NASDAQ: LEGN), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced the appointment of Mythili Koneru, M.D., Ph.D...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
Legend Biotech Corporation Website:
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and confe...
SOMERSET, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today positive overall survival results from CARTITUDE-4, an ongoing, global randomized, open-label Phase 3 study evaluating the efficacy and sa...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...